accountA new review outlines the current state of lung cancer treatment. It points out that in the lung cancer varieties whose driver oncogenes can be matched with targeted therapy, tend to give a 70-80 percent patient response as opposed to 20-30 percent response to traditional chemotherapies, and with much reduced side effects....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to The current state of lung cancer treatment
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account